tirzepatide and kidney function Cardiorenal benefits of tirzepatide. By reducing volume overload, WCN26-4259 TIRZEPATIDE FOR RESISTANT HYPERTENSION

We do have: 10+ year safety data for earlier GLP-1 agonists (liraglutide, exenatide) Growing evidence of cardiovascular benefits from weight loss medications Understanding that obesity itself has well-documented health risks The risk-benefit calculation often favors treatment, but this is an individual decision that should be made with your healthcare provider based on your specific medical situation

But luckily, I found CVREOZ

This approach removes the financial uncertainty often associated with weight loss medications, letting you focus entirely on results rather than cost escalation

Chaparro M, Guerra I, Muoz-Linares P, Gisbert JP

It does not produce the same average weight reductions seen with semaglutide (Ozempic) (injectable) in large human clinical trials

How might GLP-1 drugs like Ozempic affect your eye